linsidomine has been researched along with Kashin-Beck Disease in 2 studies
linsidomine: RN given refers to parent cpd; structure
Kashin-Beck Disease: Disabling osteochondrodysplasia with OSTEOSCLEROSIS, cone-shaped METAPHYSIS, and shortening of the DIAPHYSIS. It is endemic in parts of Siberia and northern China. Mineral deficiencies (e.g., selenium, iodine), fungal cereal contamination, and water contamination may be contributing factors in its etiology.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, H | 1 |
Fang, Q | 1 |
Wang, M | 2 |
Wang, W | 1 |
Zhang, M | 2 |
Zhang, D | 2 |
He, Y | 2 |
Zhang, Y | 2 |
Wang, H | 1 |
Otero, M | 2 |
Ma, T | 1 |
Chen, J | 2 |
Jiang, Z | 1 |
2 other studies available for linsidomine and Kashin-Beck Disease
Article | Year |
---|---|
FGF8 and FGFR3 are up-regulated in hypertrophic chondrocytes: Association with chondrocyte death in deep zone of Kashin-Beck disease.
Topics: Animals; Biomarkers; Cartilage, Articular; Cell Death; Cell Differentiation; Cell Line; Child; Child | 2018 |
3-morpholinosydnonimine (SIN-1)-induced oxidative stress leads to necrosis in hypertrophic chondrocytes in vitro.
Topics: Animals; Apoptosis; Cartilage; Case-Control Studies; Cell Line; Cell Survival; Chondrocytes; Dose-Re | 2018 |